Atlas Trials

Cryoablation Combined with Sintilimab Plus Lenvatinib in Previously Treated Unresectable Liver Metastasis from Solid Tumors

Clinical trial NCT05098847 · RECRUITING

Trial details

NCT number
NCT05098847
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Liver Metastasis
Start date
2021-10-29
Primary completion
2025-10-30
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.